Cargando…
Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications
The development of coagulation factor VIII (FVIII) inhibitory antibodies is a serious complication in hemophilia A (HA) patients after FVIII replacement therapy. Inhibitors render regular prophylaxis ineffective and increase the risk of morbidity and mortality. Immune tolerance induction (ITI) regim...
Autores principales: | Luo, Liping, Zheng, Qiaoyun, Chen, Zhenyu, Huang, Meijuan, Fu, Lin, Hu, Jianda, Shi, Qizhen, Chen, Yingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774473/ https://www.ncbi.nlm.nih.gov/pubmed/36569839 http://dx.doi.org/10.3389/fimmu.2022.1019275 |
Ejemplares similares
-
Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia
por: Chen, Yuwen, et al.
Publicado: (2022) -
Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A
por: Cai, Yuanhua, et al.
Publicado: (2020) -
Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights
por: He, Fang, et al.
Publicado: (2021) -
Pyroptosis and Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Implications
por: Ge, Yuying, et al.
Publicado: (2022) -
Escape or Fight: Inhibitors in Hemophilia A
por: Merlin, Simone, et al.
Publicado: (2020)